Skip to content
- Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic CNBC
- Ozempic copies restricted after US judge denies injunction Reuters
- Court ruling opens door to FDA action against Ozempic compounders statnews.com
- US court decision stops compounders from making knockoffs of Novo Nordisk’s semaglutide Fierce Pharma
- Patients Cut Off From Cheaper Obesity Drugs as the F.D.A. Halts Sales of Copycats The New York Times
